Uncertain impact of MPFL reconstruction added to Elmslie-Trillat for patellar dislocation .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Medial Patellofemoral Ligament Reconstruction Combined With Distal Realignment for Recurrent Dislocations of the Patella
Am J Sports Med. 2017 Feb;45(2):369-37634 patients with recurrent lateral patellar dislocation were randomized to undergo a modified Elmslie-Trillat procedure (tibial tubercle transfer) with or without the addition of medial patellofemoral ligament reconstruction. Patients were assessed over 5 year follow-up for incidence of redislocation, functional failure requiring reoperation, functional scores, and quantitative CT parameters. Overall, only one case of redislocation was documented, occurring in the control group. Functional scores did not significant differ between groups over follow-up. On CT, changes in patellar tilt and congruence angles during quadriceps contraction demonstrated better outcome in the MPFL reconstruction group compared to the control group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics